688221 logo

Frontier Biotechnologies Inc.XSSC:688221 Stock Report

Market Cap CN¥8.0b
Share Price
n/a
1Y3.2%
7D-15.8%
1D3.3%
Portfolio Value
​
View

Frontier Biotechnologies Inc.

XSSC:688221 Stock Report

Market Cap: CN¥8.0b

Frontier Biotechnologies (688221) Stock Overview

A commercial-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes various medicines that improve patients’ health in China. More details

688221 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance2/6
Financial Health4/6
Dividends0/6

Rewards

Became profitable this year

Risk Analysis

Highly volatile share price over the past 3 months compared to the CN market

Large one-off items impacting financial results


688221 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW480,485 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
BL
BlackGoat
IN
Investingwilly
RO
RockeTeller
DA
davidlsander
480,485 investors already sharing narratives
View all narratives

Frontier Biotechnologies Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Frontier Biotechnologies
Historical stock prices
Current Share PriceCN¥21.23
52 Week HighCN¥29.98
52 Week LowCN¥13.06
Beta0.88
1 Month Change10.11%
3 Month Change12.03%
1 Year Change3.21%
3 Year Change95.31%
5 Year Changen/a
Change since IPO55.30%

Recent News & Updates

Recent updates

Shareholder Returns

688221CN BiotechsCN Market
7D-15.8%-5.3%-2.5%
1Y3.2%-26.6%10.1%

Return vs Industry: 688221 exceeded the CN Biotechs industry which returned -23.8% over the past year.

Return vs Market: 688221 underperformed the CN Market which returned 10.6% over the past year.

Price Volatility

Is 688221's price volatile compared to industry and market?
688221 volatility
688221 Average Weekly Movement12.5%
Biotechs Industry Average Movement6.8%
Market Average Movement7.3%
10% most volatile stocks in CN Market12.3%
10% least volatile stocks in CN Market4.4%

Stable Share Price: 688221's share price has been volatile over the past 3 months compared to the CN market.

Volatility Over Time: 688221's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of CN stocks.

About the Company

FoundedEmployeesCEOWebsite
2002314Dong Xiewww.frontierbiotech.com

Frontier Biotechnologies Inc., a commercial-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes various medicines that improve patients’ health in China. It offers Aikening, an IV fusion inhibitor for dual therapy of HIV-1. The company’s pipeline products include FB2004 indicated for HBV; FB7011 and FB7013 for IgA nephropathy; FB7012 to treat hyperuricemia and gout; FB7041 to treat tumors; FB7024 for the treatment of hyperlipidemia; FB7023 to treat ASCVD; FB7033 for the treatment of MASH; FB4001 for osteoporosis; and FB3002 for pain management.

Frontier Biotechnologies Inc. Fundamentals Summary

How do Frontier Biotechnologies's earnings and revenue compare to its market cap?
688221 fundamental statistics
Market capCN¥7.95b
Earnings (TTM)CN¥3.46m
Revenue (TTM)CN¥392.19m
2,297x
P/E Ratio
20.3x
P/S Ratio

Is 688221 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
688221 income statement (TTM)
RevenueCN¥392.19m
Cost of RevenueCN¥83.95m
Gross ProfitCN¥308.24m
Other ExpensesCN¥304.78m
EarningsCN¥3.46m

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

Aug 31, 2026

Earnings per share (EPS)0.0092
Gross Margin78.60%
Net Profit Margin0.88%
Debt/Equity Ratio42.5%

How did 688221 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/23 08:16
End of Day Share Price 2026/07/23 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Frontier Biotechnologies Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hanyang HuangIndustrial Securities Co. Ltd.